Filter News by:

Ensure Quality Inhalation Products with Wear Debris Analysis of Medical Devices

Authors & ContributorsDavid Exline May 16, 2012 Medical devices such as inhalers tend to experience wear debris, which can cause a number of quality issues.  Characteristics of wear debris, including particle size and shape distribution, number of particles and chemistry is important to assess for specific medical devices. This webinar provides an overview of wear

Determining Content Uniformity Using Raman Chemical Imaging

May 11, 2012 Content uniformity of a drug product has a direct impact on product performance, quality and efficacy.  Raman and near-infrared chemical imaging are novel techniques used to provide an accurate, timely and cost-effective method, which is important when evaluating a drug product’s content uniformity.  By using these techniques, drug developers can ensure the

In Depth Analysis of Particle Contamination for Inhalable Drug Products

Authors & ContributorsDavid Exline April 02, 2013 The overall objective of a solid quality foundation in the evaluation of particle contamination analysis of inhalables is based on many things. The complete evaluation and root cause analysis of foreign particulate matter, as well as the affects of particulate on product quality, are essential when evaluating the

The Benefits of Using Raman Spectroscopy and LIBS for Automated Particle Identification

Authors & ContributorsDavid ExlineMarch 26, 2014 Identification of foreign particles in a drug product is a serious concern for today’s pharmaceutical drug manufactures. Manufactures often need to quickly understand where these particles come from and what they are in order to avoid potential quality concerns that could lead to an expensive recall. This webinar offers

Advancing Development of Generic OINDPs through In Vitro Testing

May 04, 2017 According to a 2007 report Measuring Trends in the Development of New Drugs: Time, Costs, Risks and Returns by J.A. DiMasi, companies spend an estimated $1.2-$1.3 billion on research and development for each approved drug due to the increasing complexity of the research and development process—particularly clinical trials. That’s a $500 million

Solving Contamination Issues with Pharmaceutical Forensics

Authors & Contributors David Exline April 22, 2011 The presence of foreign particulate matter and other contaminants can halt the production of drug products for weeks, even months, until the contaminant and the source are identified and the issue is fully resolved. This webinar recording examines how a new, advanced problem solving approach called pharmaceutical

Characterizing Pharmaceuticals Utilizing Chemical Imaging

July 26, 2011 Chemical imaging is an analytical technique that combines digital imaging with spectroscopy to characterize materials in various drug delivery systems, including nasal spray and inhalation products, semi-solids, solids, transdermal and controlled release systems, as well as medical devices. From determining a polymorphic form to evaluating the particle size distribution of an active

Laboratory Methods for Failure Analysis of Pharmaceutical Products

Authors & Contributors Rebekah Byrne David Exline May 09, 2012 Failures in pharmaceutical products may range from issues with delamination and  packaging failures to polymorphs arising in the pharmaceutical product.This webinar is designed for laboratory and manufacturing personnel that are responsible for quality assurance and quality control of processes in the manufacturing of pharmaceuticals. This